Literature DB >> 22406192

Tobacco dependence counseling in a randomized multisite clinical trial.

Ivana T Croghan1, Judith A Trautman, Theresa Winhusen, Jon O Ebbert, Frankie B Kropp, Darrell R Schroeder, Richard D Hurt.   

Abstract

Pharmacotherapy trials for treating tobacco dependence would benefit from behavioral interventions providing treatment consistent with clinical practice guidelines but not directing participants to treatments not evaluated in the trial. The Smoke Free and Living It© behavioral intervention manual includes participant and interventionist guides and is designed to provide both practical counseling and intra-treatment support. We utilized this intervention manual in a multicenter, randomized clinical trial of smokers with attention deficit hyperactivity disorder. In this study, we evaluated how the interventional manual performed in a "train-the-trainer" model requiring uniform counseling across 6 sites and 15 interventionists. We analyzed the skill-adherence of the interventionists and the intervention-adherence of the participants. The 255 randomized participants completed 9.3±2.8 sessions (mean±SD), with 157 participants (61.6%) completing all 11 of the sessions and 221 (86.7%) completing at least 6 of the 11 sessions. Of the 163 sessions for which the study interventionists were evaluated, 156 (95.7%) were rated as adherent to protocol and "meeting expectations" on at least 6 of 7 established criteria, illustrating that fidelity can be maintained with minimal supervision. The self-help and interventionists guides of the Smoke Free and Living It manual can thus be used to provide behavioral intervention with a high rate of adherence by both the interventionists and the participants. This manual meets the requirements of the United States Public Health Service Clinical Practice Guideline, can be adapted to specific research protocols, and provides a useful option for behavioral intervention during clinical trials for smoking cessation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22406192      PMCID: PMC3361527          DOI: 10.1016/j.cct.2012.02.014

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  27 in total

1.  A randomized trial of methods to help clinicians learn motivational interviewing.

Authors:  William R Miller; Carolina E Yahne; Theresa B Moyers; James Martinez; Matthew Pirritano
Journal:  J Consult Clin Psychol       Date:  2004-12

2.  Effectiveness of workshop training for psychosocial addiction treatments: a systematic review.

Authors:  Scott T Walters; Sarah A Matson; John S Baer; Douglas M Ziedonis
Journal:  J Subst Abuse Treat       Date:  2005-12

Review 3.  Measures of fidelity in motivational enhancement: a systematic review.

Authors:  Michael B Madson; Todd C Campbell
Journal:  J Subst Abuse Treat       Date:  2006-07

4.  Training Therapists in Evidence-Based Practice: A Critical Review of Studies From a Systems-Contextual Perspective.

Authors:  Rinad S Beidas; Philip C Kendall
Journal:  Clin Psychol (New York)       Date:  2010-03

Review 5.  Treatment integrity in psychotherapy research: analysis of the studies and examination of the associated factors.

Authors:  Francheska Perepletchikova; Teresa A Treat; Alan E Kazdin
Journal:  J Consult Clin Psychol       Date:  2007-12

6.  An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder.

Authors:  Lirio S Covey; Mei-Chen Hu; Carla A Green; Gregory Brigham; Richard D Hurt; Lenard Adler; Theresa Winhusen
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

7.  Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.

Authors:  R D Hurt; L C Dale; P A Fredrickson; C C Caldwell; G A Lee; K P Offord; G G Lauger; Z Marŭsić; L W Neese; T G Lundberg
Journal:  JAMA       Date:  1994-02-23       Impact factor: 56.272

8.  An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects.

Authors:  Charles S Wilcox; Nader Oskooilar; Janelle S Erickson; Sonja K Billes; Barbara B Katz; Gary Tollefson; Eduardo Dunayevich
Journal:  Addict Behav       Date:  2009-10-31       Impact factor: 3.913

9.  High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.

Authors:  L C Dale; R D Hurt; K P Offord; G M Lawson; I T Croghan; D R Schroeder
Journal:  JAMA       Date:  1995-11-01       Impact factor: 56.272

10.  Strategies for training counselors in evidence-based treatments.

Authors:  Steve Martino
Journal:  Addict Sci Clin Pract       Date:  2010-12
View more
  9 in total

1.  Anxiety and Depressed Mood Decline Following Smoking Abstinence in Adult Smokers with Attention Deficit Hyperactivity Disorder.

Authors:  Lirio S Covey; Mei-Chen Hu; Theresa Winhusen; Jennifer Lima; Ivan Berlin; Edward Nunes
Journal:  J Subst Abuse Treat       Date:  2015-07-17

2.  Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.

Authors:  Jon O Ebbert; Dorothy K Hatsukami; Ivana T Croghan; Darrell R Schroeder; Sharon S Allen; J Taylor Hays; Richard D Hurt
Journal:  JAMA       Date:  2014-01-08       Impact factor: 56.272

3.  Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.

Authors:  Ryan T Hurt; Jon O Ebbert; Ivana T Croghan; Darrell R Schroeder; Richard D Hurt; J Taylor Hays
Journal:  Drug Alcohol Depend       Date:  2018-01-02       Impact factor: 4.492

4.  Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers.

Authors:  Sean X Luo; Lirio S Covey; Mei-Chen Hu; Frances R Levin; Edward V Nunes; Theresa M Winhusen
Journal:  Am J Addict       Date:  2015-02-06

5.  A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers.

Authors:  Theresa M Winhusen; Gregory S Brigham; Frankie Kropp; Robert Lindblad; John G Gardin; Pat Penn; Candace Hodgkins; Thomas M Kelly; Antoine Douaihy; Michael McCann; Lee D Love; Eliot DeGravelles; Ken Bachrach; Susan C Sonne; Bob Hiott; Louise Haynes; Gaurav Sharma; Daniel F Lewis; Paul VanVeldhuisen; Jeff Theobald; Udi Ghitza
Journal:  J Clin Psychiatry       Date:  2014-04       Impact factor: 4.384

6.  Varenicline for Smoking Cessation in Light Smokers.

Authors:  Jon O Ebbert; Ivana T Croghan; Ryan T Hurt; Darrell R Schroeder; J Taylor Hays
Journal:  Nicotine Tob Res       Date:  2016-04-26       Impact factor: 4.244

7.  Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response.

Authors:  Edward V Nunes; Lirio S Covey; Gregory Brigham; Mei-Chen Hu; Frances R Levin; Eugene C Somoza; Theresa M Winhusen
Journal:  J Clin Psychiatry       Date:  2013-10       Impact factor: 4.384

8.  Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.

Authors:  Ryan T Hurt; Ivana T Croghan; Darrell R Schroeder; J Taylor Hays; Doo-Sup Choi; Jon O Ebbert
Journal:  Nicotine Tob Res       Date:  2017-08-01       Impact factor: 4.244

9.  Insula deep rTMS and varenicline for smoking cessation: A randomized control trial study protocol.

Authors:  Christine Ibrahim; Saima Malik; Mera S Barr; Daniel M Blumberger; Zafiris J Daskalakis; Bernard Le Foll
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.